A Non‐Fetal Chronic Residual Inflammatory Liver Phenotype After Transient Abnormal Myelopoiesis in Down Syndrome
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Transient abnormal myelopoiesis (TAM) in Down syndrome (DS) typically causes acute neonatal liver failure; however, late-onset chronic sequelae remain undercharacterized. We report two patients who, despite achieving hematologic remission, developed a persistent non-fatal inflammatory liver phenotype. Unlike the catastrophic neonatal hemochromatosis-like pathway, these cases exhibited sustained transaminase elevations and fibrotic markers triggered by immune bias rather than blast burden. We propose a two-track model of DS-TAM hepatic sequelae: (i) an acute fatal pathway, and (ii) a chronic residual inflammatory phenotype. These findings expand the clinical spectrum of TAM-associated liver disease, necessitating long-term hepatic surveillance beyond hematologic remission.
Fields of Study & Subjects
Pediatric Hepatobiliary Diseases and Treatments
Down syndrome and intellectual disability research
Acute Myeloid Leukemia Research
Publication details
- Journal / source
- Pediatric Blood & Cancer
- Volume
- 73
- Issue
- 6
- Pages
- e70280–e70280
- Publication date
- 26 March 2026
- Language
- EN